Table 1.
Patient demographics, clinicopathological data and frequencies of marker binary categories
| N (%) | |
|---|---|
| pT | |
| N = 719 | |
| 1 | 290 (40.33) |
| 2 | 369 (51.32) |
| 3 | 47 (6.54) |
| 4 | 13 (1.81) |
| pN | |
| N = 718 | |
| 0 | 80 (11.14) |
| 1 | 621 (86.49) |
| 2 | 16 (2.23) |
| 3 | 1 (0.14) |
| Histological type | |
| N = 719 | |
| Ductal | 575 (79.97) |
| Lobular | 131 (18.22) |
| Papillary | 2 (0.28) |
| Mucinous | 2 (0.28) |
| Medullary | 9 (1.25) |
| Histological grade | |
| N = 694 | |
| I | 102 (14.70) |
| II | 287 (41.35) |
| III | 305 (43.95) |
| Adjuvant chemotherapy | |
| N = 719 | |
| Docetaxel | 357 (49.65) |
| Vinorelbine | 362 (50.35) |
| HER2-pos | |
| N = 163 | |
| Trastuzumab | 83 (50.92) |
| No Trastuzumab | 80 (49.08) |
| Type of Surgery | |
| N = 719 | |
| Total Mastectomy | 430 (59.81) |
| Breast Conserving | 289 (40.19) |